| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.28 | 1e-17 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.18 | 9e-08 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.58 | 0.0003 |